Patents Assigned to Fluoromed Pharmaceutical, Inc.
  • Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport
    Patent number: 4865836
    Abstract: A brominated perfluorocarbon emulsion non-toxic for internal and intravenous use in animals including humans for use as an oxygen transport medium and as a tumor and other element contrast enhancement medium is stable with very small size characteristics for extended periods in excess of eighteen months and after sterilization, with a stabilizing component selected from the class comprising steroid hormones, tocopherols, cholesterols and their combinations. An anti-oxidizing component enhances delivery in oxygen transport.
    Type: Grant
    Filed: January 14, 1986
    Date of Patent: September 12, 1989
    Assignee: Fluoromed Pharmaceutical, Inc.
    Inventor: David M. Long, Jr.